Interview: siRNA-Loaded Stem Cell Exosomes, Inside NurExone Biologic’s Spinal Cord Injury Candidate
NurExone's SCI candidate showed 100% gait recovery in rat models, and they're gearing up for human trials hopefully in 2026. Enjoy the interview!
Neurology
TheWell Bioscience Introduces VitroGel® NEURON, a Synthetic Hydrogel Enhancing Neuronal Cell Culture
Designed for 2D and 3D cultures, this platform aims to offer greater consistency and scalability in neuronal research.
Tel Aviv University to Implant Lab-Grown Spinal Cord in Human Trial, Derived from Stem Cells
Researchers have seen good success in animal studies, and are advancing to the first clinical trials in humans. What a time to be alive.
Indiana University Opens New Stem Cell Research Center for Alzheimer’s and Dementias
Indiana University’s new MAP-AD center will use stem-cell-derived brain models and AI to advance Alzheimer’s research and drug development.
Klotho Neurosciences to Acquire Turn Biotechnologies Assets, Secures $300 Million Deal
Klotho Neurosciences expands into cellular reprogramming with a planned Turn Biotechnologies acquisition and significant pharma partnership.
DarwinCell Presents Mesenchymal Stem Cell ALS Therapy at American Neurological Association Meeting
The Chinese biotech company shared promising preclinical and early clinical results for its novel ALS therapy
Aspen Neuroscience Begins Third Cohort in Parkinson’s Disease Stem Cell Therapy Trial with Commercial Formulation
Aspen’s trial advances with a commercial-ready, patient-derived cell therapy aiming to improve Parkinson’s outcomes and streamline clinical delivery.
BlueRock Therapeutics Begins Phase III Trial of Stem Cell Therapy for Parkinson’s Disease
The exPDite-2 trial will evaluate the safety and effectiveness of donor-derived stem cell therapy in Parkinson’s disease patients.
Orthocell’s Collagen Nerve Wrap, Remplir, Now Available to Australian Urologists for Prostate Surgery Recovery
Australian urologists can now access Remplir to support nerve protection and recovery during robotic prostate cancer surgeries.
RBI Launching Phase 2 Brain Stem Cell Injection Trial for Alzheimer’s
The trial will inject autologous stem cells directly into the brain to bypass the blood-brain-barrier.
